文献速递心血管MR

负荷心脏磁共振对已知冠心病患者的预后价值

Prognostic Value of Stress Cardiac Magnetic Resonance in Patients With Known Coronary Artery Disease.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-08-18

基于美国SPINS多中心注册研究,纳入755例已知冠心病患者,中位随访5.3年,负荷CMR显示缺血与心梗/心血管死亡(HR 2.30)及MACE(HR 2.24)显著相关,多因素校正后仍显著(HR 1.84、1.77),并可将95%的中危患者重新分类,无缺血者年心梗/心血管死亡率<2%。

要点

  • 负荷CMR评估的缺血与已知冠心病患者心梗/心血管死亡独立相关(多因素校正HR 1.84)。
  • 缺血可将95%的中危患者重新分类,低危和高危患者年事件率分别为1.4%和5.3%。
  • 无缺血者年心梗/心血管死亡发生率<2%。

核心结论

  • 在已知冠心病多中心队列中,CMR评估的缺血与心梗/心血管死亡强烈相关,并可在心血管危险因素之外重新分类患者风险,尤其在中危患者中;无缺血与年心梗/心血管死亡率<2%相关。

研究设计与样本

  • 来自美国SPINS注册研究的连续已知冠心病患者,因评估心肌缺血转诊行负荷CMR,共755例(年龄64±11岁,64%男性),中位随访5.3年。

诊断标准与关键数值

  • 缺血与心梗/心血管死亡显著相关(HR 2.30,95%CI 1.54-3.44,P<0.001),与MACE显著相关(HR 2.24,95%CI 1.69-2.95,P<0.001)。
  • 多因素校正心血管危险因素后,缺血仍与心梗/心血管死亡相关(HR 1.84,95%CI 1.17-2.88,P=0.008),与MACE相关(HR 1.77,95%CI 1.31-2.40,P<0.001)。
  • 缺血重新分类95%的中危患者(62%降至低危,33%升至高危),低危和高危患者年事件率分别为1.4%和5.3%。

临床应用与阅片要点

  • 负荷CMR评估的缺血可用于已知冠心病患者的风险分层,尤其有助于中危患者的风险再分类。
  • 无缺血提示年心梗/心血管死亡风险<2%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to determine whether stress cardiac magnetic resonance (CMR) provides clinically relevant risk reclassification in patients with known coronary artery disease (CAD) in a multicenter setting in the United States.

BACKGROUND: Despite improvements in medical therapy and coronary revascularization, patients with previous CAD account for a disproportionately large portion of CV events and pose a challenge for noninvasive stress testing.

METHODS: From the Stress Perfusion Imaging in the United States (SPINS) registry, we identified consecutive patients with documented CAD who were referred to stress CMR for evaluation of myocardial ischemia. The primary outcome was nonfatal myocardial infarction (MI) or cardiovascular (CV) death. Major adverse CV events (MACE) included MI/CV death, hospitalization for heart failure or unstable angina, and late unplanned coronary artery bypass graft. The prognostic association and net reclassification improvement by ischemia for MI/CV death were determined.

RESULTS: Out of 755 patients (age 64 ± 11 years, 64% male), we observed 97 MI/CV deaths and 210 MACE over a median follow-up of 5.3 years. Presence of ischemia demonstrated a significant association with MI/CV death (HR: 2.30; 95% CI: 1.54-3.44; P < 0.001) and MACE (HR: 2.24 ([95% CI: 1.69-2.95; P < 0.001). In a multivariate model adjusted for CV risk factors, ischemia maintained strong association with MI/CV death (HR: 1.84; 95% CI: 1.17-2.88; P = 0.008) and MACE (HR: 1.77; 95% CI: 1.31-2.40; P < 0.001) and reclassified 95% of patients at intermediate pretest risk (62% to low risk, 33% to high risk) with corresponding changes in the observed event rates of 1.4% and 5.3% per year for low and high post-test risk, respectively.

CONCLUSIONS: In a multicenter cohort of patients with known CAD, CMR-assessed ischemia was strongly associated with MI/CV death and reclassified patient risk beyond CV risk factors, especially in those considered to be at intermediate risk. Absence of ischemia was associated with a <2% annual rate of MI/CV death. (Stress CMR Perfusion Imaging in the United States [SPINS] Study; NCT03192891).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Antiochos P, Ge Y, Heydari B, et al. Prognostic Value of Stress Cardiac Magnetic Resonance in Patients With Known Coronary Artery Disease. JACC Cardiovasc Imaging. 2021. PMID: 34419400. doi:10.1016/j.jcmg.2021.06.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。